-
Views
-
Cite
Cite
K. HERMANSEN, Effects of Cholecystokinin (CCK)-4, Nonsulfated CCK-8, and Sulfated CCK-8 on Pancreatic Somatostatin, Insulin, and Glucagon Secretion in the Dog: Studies in Vitro, Endocrinology, Volume 114, Issue 5, 1 May 1984, Pages 1770–1775, https://doi.org/10.1210/endo-114-5-1770
- Share Icon Share
Abstract
The effect of cholecystokinin (CCK)-4, nonsulfated CCK-8 (CCK-8), and sulfated CCK-8 (CCK-8-S) on endocrine pancreas function was investigated in the isolated perfused dog pancreas in the presence of 5.5 mm glucose. CCK-4 and CCK-8 at concentrations of 1, 10, and 100 nm dose dependently stimulated pancreatic SRIF, insulin, and glucagon release. The insulinotropic and glucagonotropic potency of CCK-8 was significantly greater than that of CCK-4, whereas the effect on SRIF secretion was similar. Furthermore, CCK-8-S and CCK-8 at concentrations of 0.1,1, and 10 nm caused a dose-dependent increase in pancreatic A, B, and D cell secretion. The CCK-8-S was a more potent insulinotropic agent than CCK-8. It is suggested that these principal molecular CCK forms qualify for a physiological modulatory role in the endocrine pancreas. (Endocrinology114: 1770, 1984)